Ovation Science Inc. (CSE:OVAT)

Market Cap	1.54M
Revenue (ttm)	63.82K
Net Income (ttm)	-417.02K
Shares Out	38.41M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,100
Average Volume	43,272
Open	0.0400
Previous Close	0.0400
Day's Range	0.0400 - 0.0400
52-Week Range	0.0250 - 0.0800
Beta	0.44
RSI	49.62
Earnings Date	May 1, 2026

About Ovation Science

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company’s patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OVAT

Financial Performance

In 2024, Ovation Science's revenue was 113,215, an increase of 82.80% compared to the previous year's 61,934. Losses were -456,197, -43.90% less than in 2023.